FDA Reform Bill Could Still Face Administrative Gauntlet After Enactment
This article was originally published in The Pink Sheet Daily
Executive Summary
Implementation of new FDA drug safety authorities may not be quick or easy if lengthy rule-making is a prerequisite to action.